Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.96 USD | -18.48% | -19.55% | +34.87% |
May. 10 | Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says | MT |
May. 10 | Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
Financials (USD)
Sales 2024 * | 165M | Sales 2025 * | 431M | Capitalization | 3.07B |
---|---|---|---|---|---|
Net income 2024 * | -350M | Net income 2025 * | -243M | EV / Sales 2024 * | 17.5 x |
Net cash position 2024 * | 178M | Net cash position 2025 * | 144M | EV / Sales 2025 * | 6.78 x |
P/E ratio 2024 * |
-8.49
x | P/E ratio 2025 * |
-15.3
x | Employees | 557 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.59% |
Latest transcript on Iovance Biotherapeutics, Inc.
1 day | -18.48% | ||
1 week | -19.55% | ||
Current month | -6.92% | ||
1 month | -12.84% | ||
3 months | +19.44% | ||
6 months | +176.20% | ||
Current year | +34.87% |
Managers | Title | Age | Since |
---|---|---|---|
Frederick Vogt
CEO | Chief Executive Officer | 50 | 16-09-29 |
Director of Finance/CFO | 51 | 20-12-13 | |
Brian Shew
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Merrill McPeak
BRD | Director/Board Member | 88 | 11-07-19 |
Director/Board Member | 56 | 16-06-06 | |
Michael Weiser
BRD | Director/Board Member | 61 | 18-03-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.95% | 11 M€ | -6.03% | - | |
0.93% | 0 M€ | 0.00% | - | |
0.14% | 0 M€ | 0.00% | - | |
0.11% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 10.96 | -18.48% | 19,262,073 |
24-05-09 | 13.45 | +0.45% | 4,733,950 |
24-05-08 | 13.39 | -4.22% | 4,231,022 |
24-05-07 | 13.98 | +0.72% | 3,954,679 |
24-05-06 | 13.88 | +1.83% | 4,862,854 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.87% | 3.07B | |
-27.67% | 9.87B | |
-17.30% | 2.73B | |
-11.15% | 2.24B | |
-22.32% | 1.63B | |
+59.69% | 1.39B | |
+23.58% | 771M | |
-1.31% | 760M | |
-28.57% | 516M | |
+5.37% | 310M |
- Stock Market
- Equities
- IOVA Stock